Skip to main content
Log in

Arsenic toxicity in humans: Research problems and prospects

  • Published:
Environmental Geochemistry and Health Aims and scope Submit manuscript

Abstract

The disposition and toxicity of the metalloid, arsenic, is affected by its oxidation state and on the extent to which it is converted to methylated species. Given that these chemical modifications influence the fate and action of arsenic, new research efforts should be directed both towards elucidating the molecular processes involved in the metabolism of arsenic and in characterising interindividual variation in capacity for processes such as the methylation of arsenic. This information will contribute to a better understanding of the mechanisms of arsenic toxicity and carcinogenicity and to a better assessment of the hazards associated with chronic exposure to this agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bencko, V., Benes, B. and Cirkt, M. 1976. Biotransformation of As(III) to As(V) and As tolerance.Arch. Toxicol.,36, 159–162.

    Google Scholar 

  • Bogdan, G.M. and Aposhian, H.V. 1991. Enzymatic reduction of arsenate to arsenite in rat and rabbit liver, (abstract)The Toxicologist,11, 1254.

    Google Scholar 

  • Buchet, J.P., Lauwerys, R. and Roels, H. 1981a. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsenate in man.Int. Arch. Occup. Environ. Health,48, 71–79.

    Google Scholar 

  • Buchet, J.P., Lauwerys, R. and Roels, H. 1981b. Urinary excretion of inorganic As and its metabolites after repeated ingestion of sodium metaarsenite by volunteers.Int. Arch. Occup. Environ. Health,48, 111–118.

    Google Scholar 

  • Buchet, J.P. and Lauwerys, R. 1988. Role of thiols in thein vitro methylation of inorganic arsenic by rat liver cytosol.Biochem. Pharmacol., 37, 3149–3153.

    Google Scholar 

  • Cikrt, M., Mravcova, A., Malatova, I. and Bencko, V. 1988. Distribution and excretion of74As and75Se in rats after their simultaneous administration. The effect of arsenic, selenium and combined treatment.J. Hyg. Epidemiol. Microbiol. Immunol.,32, 17–29.

    Google Scholar 

  • Clarke, S. 1992. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues.Ann. Rev. Biochem.,61, 355–386.

    Google Scholar 

  • Cohen, M., Latta, D., Coogan, T. and Costa, M. 1990. Mechanisms of metal carcinogenesis: The reaction of metals with nucleic acids. In: Foulkes, E.C. (ed.),Biological Effects of Heavy Metals-Metal Carcinogenesis, Vol. II, pp. 19–75. CRC Press, Boca Raton, Florida.

    Google Scholar 

  • Cuzick, J., Evans, S., Gillman, M. and Price Evans, D. 1982. Medical arsenic and internal malignancies.Br. J. Cancer,45, 904–911.

    Google Scholar 

  • Del'Razo, L.M., Arellano, M.A. and Cebrian, M.E. 1990. The oxidation states of arsenic in well-water from a chronic arsenicism area of Northern Mexico.Environ. Pollution,64, 143–153.

    Google Scholar 

  • Doerfler, W. 1983. DNA methylation and gene activity.Ann. Rev. Biochem.,52, 93–124.

    Google Scholar 

  • Fierz, U. 1965. [Catamnestic investigation of the side effects of therapy of skin disease with inorganic arsenic] in German.Dermatologica,131, 41–58.

    Google Scholar 

  • Franke, K.W. and Moxon, A.L. 1936. A comparison of the minimum fatal dose of selenium, tellurium, arsenic and vanadium.J. Pharmacol. Exp.Ther.,58, 454–459.

    Google Scholar 

  • Ganther, H.E. 1979. Metabolism of hydrogen selenide and methylated selenides. In: Draper. H.H. (ed.),Advances in Nutritional Research, pp. 107–129. Plenum, New York.

    Google Scholar 

  • Hertz-Picciotto, I., Smith, A.H., Holtzman, D., Lipsett, M. and Alexeeff, G. 1992. Synergism between occupational arsenic exposure and smoking in the induction of lung cancer.Epidemiol.,3, 23–31.

    Google Scholar 

  • Hirata, M., Mohri, T., Hisanaga, A. and Ishinishi, N. 1989. Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from the liver and kidneys of rats and mice.Appl. Organometallic Chem.,3, 335–341.

    Google Scholar 

  • Hsieh, H.S. and Ganther, H.E. 1977. Biosynthesis of dimethyl selenide from sodium selenite in rat liver and kidney cell-free systems.Biochim. Biophys. Acta,497, 205–217.

    Google Scholar 

  • International Agency for Research on Cancer 1987. Arsenic and arsenic compounds. In:IARC Monograph on the Evaluation of Carcinogenic Risks to Humans — Overall Evaluations of Carcinogenicity: An Update of IARC Monographs 1 to 42. Suppl. 7, pp. 100–106, IARC, Lyon.

    Google Scholar 

  • Levander, O.A. and Baumann, C.A. 1966. Selenium metabolism. V. Studies on the distribution of selenium in rats given arsenic.Toxicol. Appl. Pharmacol.,9, 98–105.

    Google Scholar 

  • Marfante, E. and Vahter, M. 1984. The effect of methyltransferase inhibition on the metabolism of [74As] arsenite in mice and rats.Chem.-Biol. Interact.,50, 49–57.

    Google Scholar 

  • Mass, M.J. 1992. Human carcinogenesis by arsenic.Environ. Geochem. Health,14, 49–54.

    Google Scholar 

  • McKinney, J.D. 1992. Metabolism and disposition of inorganic arsenic in laboratory animals and humans.Environ. Geochem. Health,14, 43–48

    Google Scholar 

  • Michalowsky, L.A. and Jones, P.A. 1989. DNA methylation and differentiation.Environ. Health Perspect.,80, 189–197.

    Google Scholar 

  • Mozier, N.M., McConnell, K.P. and Hoffman, J.L. 1988. S-adenosyl-L-methionine: thioester-S-methyltransferase, a new enzyme in sulfur and selenium metabolism.J. Biol. Chem.,263, 4527–4531.

    Google Scholar 

  • Newberne, P.M. and Rogers, A.E. 1986. Labile methyl groups and the promotion of cancer.Ann. Rev. Nutr.,6, 407–432.

    Google Scholar 

  • Paik, W.K. and Kim, S. 1990.Protein Methylation. CRC Press, Boca Raton, Florida.

    Google Scholar 

  • Petito, C.T. and Beck, B.D. 1991. Evaluation of evidence of nonlinearities in the dose-response curve for arsenic carcinogenesis.Trace Substances in Environmental Health,24, 143–176.

    Google Scholar 

  • Rogers, E.H., Chernoff, N. and Kavlock, R.J. 1981. The teratogenic potential of cacodylic acid in the rat and mouse.Drug Chem. Toxicol.,4, 49–61.

    Google Scholar 

  • Smith, A.H., Hopenhayn-Rich, C., Bates, M.N., Goeden, H.M., Hertz-Picciotto, I., Duggan, H.M., Wood, R., Kosnett, M.J. and Smyth, M.T. 1992. Cancer risks from arsenic in drinking water.Environ. Health Perspect.,97, 259–267.

    Google Scholar 

  • Suzuki, D.T. and Griffiths, A.J.E. 1976.An Introduction to Genetic Analysis, pp. 403–411. Freeman, San Francisco.

    Google Scholar 

  • US Environmental Protection Agency 1988.Special Report on Ingested Inorganic Arsenic — Skin Cancer;Nutritional Essentiality. US EPA/625-87, July 1988, 124 pp. Washington, D.C.

  • Vahter, M. 1981. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats.Environ. Res.,25, 286–293.

    Google Scholar 

  • Vahter, M. and Envall, J. 1983. In vivo reduction of arsenate in mice and rabbits.Environ. Res.,32, 14–24.

    Google Scholar 

  • Weinshilboum, R. 1988. Pharmacogenetics of methylation: Relationship to drug metabolism.Clin. Biochem.,21, 201–210.

    Google Scholar 

  • Yamanaka, K., Hasegawa, A., Sawamura, R. and Okada, S. 1989. Dimethylated arsenics induce DNA strand breaks in lungvia the production of active oxygen in mice.Biochem. Biophys. Res. Commun.,165, 43–50.

    Google Scholar 

  • Yamanaka, K., Hoshino, H., Okamoto, M., Sawamura, R., Hasegawa, A., and Okada, S. 1990. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical.Biochem. Biophys. Res. Commun.,168, 58–64.

    Google Scholar 

  • Yamanaka, K., Hasegawa, A., Sawamura, R. and Okada, S. 1991. Cellular responses to oxidative damage in lung induced by the administration of dimethylarsenic acid, a metabolite of inorganic arsenics, in mice.Toxicol. Appl. Pharmacol.,108, 205–215.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, D.J. Arsenic toxicity in humans: Research problems and prospects. Environ Geochem Health 16, 107–111 (1994). https://doi.org/10.1007/BF01747906

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01747906

Keywords

Navigation